Why Johnson & Johnson’s (JNJ) Stock Is Down 5.63%
As of Tuesday, October 13, Johnson & Johnson’s JNJ share price has dipped by 5.63%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
Jenna Brashear
| Share Statistics | JNJ | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $651,105.2 | $421.5 | 100% |
|
| Shares Out (Mil) | 2,448.6 | 46.9 | 98% |
|
| Institutional Ownership | 100.0% | 82.0% | 99% |
|
| Float (Mil) | 2,403.6 | 49.2 | 96% |
|
| Beta | 0.20 | 0.68 | 12% |
|
| Avg Daily Volume (000s) | 8,160 | 347 | 95% |
|
| Price Change (52-week) |
33.6% | 49.3% | 81% |
|
| Growth | JNJ | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.7% | 6.4% | 27% |
|
| Net Income (5yr) | 12.7% | (1.3%) | 60% |
|
| EPS (5yr) | 14.9% | 15.1% | 56 |
|
| Dividends (5yr) | 5.2% | 0.0% | 98% |
|
| Cash Flow (5yr) | (7.7%) | (15.0%) | 59% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 17 | 22 | 23 | |
| Current EPS | $2.916 | $11.118 | $11.612 | |
| Month Ago EPS | $2.915 | $11.120 | $11.618 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $3.025 | $11.053 | $12.308 | |
| Year/Year Chg | 3,252% | 0.8% | 25.8% | |
| Financials | JNJ | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $99,335 | $275 | 99% |
|
| Net Income (TTM) (Mil) | $16,095 | ($11) | 99% |
|
| EPS (TTM) | $6.684 | ($0.700) | 90% |
|
| Operating Cash Flow (TTM) (Mil) | $26,159 | ($7) | 99% |
|
| Net Cash Flow (TTM) (Mil) | ($1,321) | $1 | 2% |
|
| Long-Term Debt (Q1) (Mil) | $35,799 | $6 | 97% |
|
| Enterprise Value (Q1) (Mil) | $715,312 | $331 | 100% |
|
| Valuation | JNJ | Industry Median |
Percentile (All Stocks) |
|
| P/B | 7.99 | 2.08 | 91% |
|
| P/E | 41.1 | 20.9 | 84% |
|
| Dividend Yield | 2.0% | 0.0% | 75% |
|
| PEG (5yr hist) | 2.8 | 1.1 | 79% |
|
| Ratios | JNJ | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 67.8% | 69.5% | 80% |
|
| Net Margin | 16.2% | 3.6% | 74% |
|
| ROA | 8.2% | (23.8%) | 82% |
|
| ROE | 20.0% | (24.2%) | 79% |
|
| Liabilities to Assets | 58.7% | 31.6% | 53% |
|
| F-Score | 5 | 3 | 50% |
|
Johnson & Johnson did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors